{"id":322643,"date":"2019-01-28T12:14:05","date_gmt":"2019-01-28T12:14:05","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=322643"},"modified":"2019-01-28T12:14:05","modified_gmt":"2019-01-28T12:14:05","slug":"creative-biolabs-releases-replicationcompetent-virus-testing-service","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/creative-biolabs-releases-replicationcompetent-virus-testing-service_322643.html","title":{"rendered":"Creative Biolabs Releases Replication-Competent Virus Testing Service"},"content":{"rendered":"
New York, US\u2013Jan 28, 2019 Creative Biolabs, a CRO specializing in antibody discovery and immune cell based therapy, now releases a replication-competent virus testing service for gene-mediated cell therapy and viral vector-based gene therapy programs, intending to help global customers move the viral vector-based therapy into the clinic more quickly.<\/p><\/div>\n

New York, US–<\/strong>Jan 28<\/strong>, 201<\/strong>9<\/strong>  Creative Biolabs, a CRO specializing in antibody discovery and immune cell based therapy<\/a>, now releases a replication-competent virus testing service for gene-mediated cell therapy and viral vector-based gene therapy programs, intending to help global customers move the viral vector-based therapy into the clinic more quickly.<\/p>\n

 <\/p>\n

Compared to the traditional methods, such as invasive surgeries, radiation and chemotherapy, chimeric antigen receptor (CAR)-engineered T cell therapy is characterized by higher specificity and less toxicity, which has become the most promising immunotherapy and has shown remarkable ability to eliminate various kinds of tumors.<\/p>\n

 <\/p>\n

“Despite the wide application and powerful usage of viral vectors in gene therapies and gene-mediated cell therapies for a variety of inherited and acquired diseases, it is challenging to move any viral vector into the clinic due to the limits from the presence of replication-competent lentivirus (RCL) or replication-competent retrovirus (RCR). Therefore, during the various stages of vector preparation and ex vivo<\/em> patient treatment, replication-competent virus (RCV) testing<\/a> plays an essential role to test viruses which may have been produced through recombination. Meanwhile, assay development for RCL\/RCR is also particularly challenging.” said a scientist from Creative Biolabs.<\/p>\n

 <\/p>\n

“We fully understand the needs and importance. Based on the advanced GLP\/GMP testing platform, our Ph.D. level scientists and skillful technicians can provide a high-quality replication-competent virus testing service and effectively perform the RCL\/RCR testing abiding by the FDA guidance, ensuring patients are not inadvertently exposed to replicating virus.”<\/p>\n

 <\/p>\n

With years of experience, Creative Biolabs has established several world-leading platforms to serve worldwide clients with academic or clinical requirements. Besides replication-competent virus testing services, Creative Biolabs can deliver a wide range of CAR T immunotherapy<\/a> services that are tailored to clients’ individual requirements in terms of science, timelines, and cost. For more information, please visit https:\/\/www.creative-biolabs.com\/car-t\/<\/a>.<\/p>\n

 <\/p>\n

About Creative Biolabs<\/p>\n

As a global company, Creative Biolabs has more than 200 talented and well-trained scientists located in different continents working closely with partners from the entire world to develop and produce medicines of tomorrow. Specifically, the established leading experts in TCR and CAR T&NK cell immune therapy development offer the one-stop custom services that cover the entire new drug development pipeline, and an exclusive line of ready-to-use TCR and CAR T&NK cell construction products, such as virus packaging, purification, expansion and titer determination kits. Furthermore, a unique unparalleled CAR construction and production platform has been built up for all four CAR generations.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Creative Biolabs
Contact Person:<\/strong> Candy Swift
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 1-631-619-7922
Address:<\/strong>45-1 Ramsey Road
City:<\/strong> Shirley
State:<\/strong> New York
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.creative-biolabs.com\/car-t\/<\/a><\/p>\n

<\/object><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

New York, US\u2013Jan 28, 2019 Creative Biolabs, a CRO specializing in antibody discovery and immune cell based therapy, now releases a replication-competent virus testing service for gene-mediated cell therapy and viral vector-based gene therapy programs, intending to help global customers … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-322643","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/322643","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=322643"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/322643\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=322643"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=322643"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=322643"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}